Abirtega — Medica
Prostate cancer post radical prostatectomy or radiation therapy
Initial criteria
- age ≥ 18 years
- used in combination with prednisone
- ONE of the following: prostate specific antigen (PSA) persistence or recurrence following radical prostatectomy OR PSA recurrence or positive digital rectal examination (DRE) after radiation therapy
- pelvic nodal recurrence or positive regional lymph nodes
- ONE of the following: concurrently used with a gonadotropin-releasing hormone (GnRH) analog OR patient has had a bilateral orchiectomy
Approval duration
1 year